These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 8445035)

  • 1. Octreotide reverses hyperinsulinemia and prevents hypoglycemia induced by sulfonylurea overdoses.
    Boyle PJ; Justice K; Krentz AJ; Nagy RJ; Schade DS
    J Clin Endocrinol Metab; 1993 Mar; 76(3):752-6. PubMed ID: 8445035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of octreotide and standard therapy versus standard therapy alone for the treatment of sulfonylurea-induced hypoglycemia.
    Fasano CJ; O'Malley G; Dominici P; Aguilera E; Latta DR
    Ann Emerg Med; 2008 Apr; 51(4):400-6. PubMed ID: 17764782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Octreotide for the treatment of sulfonylurea poisoning.
    Glatstein M; Scolnik D; Bentur Y
    Clin Toxicol (Phila); 2012 Nov; 50(9):795-804. PubMed ID: 23046209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Octreotide for sulfonylurea-induced hypoglycemia following overdose.
    Carr R; Zed PJ
    Ann Pharmacother; 2002 Nov; 36(11):1727-32. PubMed ID: 12398568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of subcutaneous octreotide in patients with sulfonylurea-induced hypoglycemia and congestive heart failure.
    Vallurupalli S
    Ann Pharmacother; 2010 Feb; 44(2):387-90. PubMed ID: 20118140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of sulfonylurea and insulin overdose.
    Klein-Schwartz W; Stassinos GL; Isbister GK
    Br J Clin Pharmacol; 2016 Mar; 81(3):496-504. PubMed ID: 26551662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of sulfonylurea ingestions.
    Spiller HA
    Pediatr Emerg Care; 1999 Jun; 15(3):227-30. PubMed ID: 10389964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Octreotide: an antidote for sulfonylurea-induced hypoglycemia.
    McLaughlin SA; Crandall CS; McKinney PE
    Ann Emerg Med; 2000 Aug; 36(2):133-138. PubMed ID: 10918104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Octreotide for the treatment of intentional insulin aspart overdose in a non-diabetic patient.
    Dewaal CM; McGillis E; Mink M; Lucyk S
    CJEM; 2018 Jul; 20(4):643-647. PubMed ID: 29202888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous octreotide infusion for sulfonylurea-induced hypoglycemia in a toddler.
    Llamado R; Czaja A; Stence N; Davidson J
    J Emerg Med; 2013 Dec; 45(6):e209-13. PubMed ID: 23827165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Octreotide's role in the management of sulfonylurea-induced hypoglycemia.
    Dougherty PP; Klein-Schwartz W
    J Med Toxicol; 2010 Jun; 6(2):199-206. PubMed ID: 20352540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effectiveness of various doses of octreotide for sulfonylurea-induced hypoglycemia after overdose.
    Gul M; Cander B; Girisgin S; Ayan M; Kocak S; Unlu A
    Adv Ther; 2006; 23(6):878-84. PubMed ID: 17276956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical spectrum of sulfonylurea overdose and experience with diazoxide therapy.
    Palatnick W; Meatherall RC; Tenenbein M
    Arch Intern Med; 1991 Sep; 151(9):1859-62. PubMed ID: 1888253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bench-to-bedside review: Antidotal treatment of sulfonylurea-induced hypoglycaemia with octreotide.
    Lheureux PE; Zahir S; Penaloza A; Gris M
    Crit Care; 2005; 9(6):543-9. PubMed ID: 16356235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended-release glipizide overdose presenting with delayed hypoglycemia and treated with subcutaneous octreotide.
    Pelavin PI; Abramson E; Pon S; Vogiatzi MG
    J Pediatr Endocrinol Metab; 2009 Feb; 22(2):171-5. PubMed ID: 19449674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Octreotide for hypoglycemia caused by sulfonylurea and DPP-4 inhibitor.
    Yamaguchi S; Ikejima M; Furukawa A; Abe M; Nakazaki M; Ishihara H
    Diabetes Res Clin Pract; 2015 Aug; 109(2):e8-e10. PubMed ID: 26025695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Octreotide for the treatment of hypoglycemia after insulin glargine overdose.
    Groth CM; Banzon ER
    J Emerg Med; 2013 Aug; 45(2):194-8. PubMed ID: 23669130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the use and safety of octreotide as antidotal therapy for sulfonylurea overdose in children.
    Dougherty PP; Lee SC; Lung D; Klein-Schwartz W
    Pediatr Emerg Care; 2013 Mar; 29(3):292-5. PubMed ID: 23426239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pasireotide (SOM230) prevents sulfonylurea-induced hypoglycemia in rats.
    Schmid HA
    Exp Clin Endocrinol Diabetes; 2015 Mar; 123(3):193-7. PubMed ID: 25658662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient hyperinsulinism in an asphyxiated newborn infant with hypoglycemia.
    Clark W; O'Donovan D
    Am J Perinatol; 2001 Jun; 18(4):175-8. PubMed ID: 11444360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.